Simons, E, et al.
Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data. Lancet
2012; 379: 2173–2178.
World Health Organization. Strategic plan for measles and congenital rubella infection in the WHO European Region. Copenhagen, Denmark: WHO Regional Office for Europe, 2003.
Khetsuriani, N, et al.
Supplementary immunization activities to achieve measles elimination: experience of the European region. Journal Infectious Diseases
2011; 204 (Suppl. 1): 343–352.
European Centre for Disease Prevention and Control (ECDC). European monthly measles monitoring (EMMO). Issue 10. Stockholm: ECDC, 2012.
Muscat, M. Who gets measles in Europe?
Journal Infectious Diseases
2011; 204 (Suppl. 1): 353–365.
Van Lier, EA, et al. Vaccination coverage national immunization program the Netherlands [in Dutch]. Bilthoven, The Netherlands: National Institute for Public Health and the Environment, 2012. Report 201001001/2012.
Ruijs, WL, et al.
Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study. BMC Public Health
2011; 11: 102.
Bijkerk, H, Bilkert-Mooiman, MA, Houtters, HJ. The immunization status of patients registered with measles during the 1987–88 epidemic [in Dutch]. Nederlands Tijdschrift voor Geneeskunde
1989; 133: 29–32.
Van der Zwan, CW, et al.
Measles in the Netherlands: epidemiology and the effect of vaccination [in Dutch]. Nederlands Tijdschrift voor Geneeskunde
1994; 138: 2390–2395.
Wallinga, J, van den Hof, S. Measles epidemiology in the Netherlands: an exploratory analysis of notification [in Dutch]. Nederlands Tijdschrift voor Geneeskunde
2000; 144: 171–174.
Van den Hof, S, Conyn-van Spaendonck, MAE, van Steenbergen, JE. Measles epidemic in the Netherlands, 1999–2000. Journal Infectious Diseases
2002; 186: 1483–1486.
Hahné, S, et al.
Measles outbreak, the Netherlands, 2008. Emerging Infectious Diseases
2010; 16: 567–568.
Van den Hof, S, et al.
Sero-epidemiologic study of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in municipalities with low vaccine coverage. Vaccine
2000; 18: 931–940.
De Melker, HE, Conyn-van Spaendonck, MA. Immunosurveillance and the evaluation of national immunization programmes: a population-based approach. Epidemiology and Infection
1998; 121: 637–643.
Van der Klis, FRM, et al.
Second national serum bank for population-based seroprevalence studies in the Netherlands. Netherlands Journal of Medicine
2009; 67: 301–308.
Smits, GP, et al.
Development of a bead-based multiplex immunoassay for the simultaneously quantitative detection of IgG serum antibodies against measles, mumps, rubella and varicella zoster. Clinical Vaccine Immunology
2012; 19: 396–400.
Chen, RT, et al.
Measles antibody: reevaluation of protective titers. Journal Infectious Diseases
1990; 162: 1036–1042.
The R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2011.
Statistics Netherlands. Population on 1 January 2007 (http://www.cbs.nl). Accessed 1 January 2009.
Statistics Netherlands. Degree of urbaniziation per municipality (http://www.cbs.nl). Accessed 1 October 2007.
Ruijs, WLM, et al.
Measuring vaccination coverage in a hard to reach minority. European Journal of Public Health
2012; 22: 359–364.
Bickel, PJ, Doksum, KA. Basic heuristics of estimation. In: Bickel, PJ and Doksum, KA, eds. Mathematical Statistics. Basic Ideas and Selected Topics. London: Prentice-Hall, 2001, pp. 101.
Gay, NJ. The theory of measles elimination: implications for the design of elimination strategies. Journal Infectious Diseases
2004; 189 (Suppl. 1): 27–35.
Wallinga, J, Heijne, JCM, Kretzschmar, M. A measles epidemic threshold in a highly vaccinated population. PLoS Medicine
2005; 2: e316.
Bartlett, MS. The critical community size for measles in the United States. Journal of the Royal Statistical Society. Series A (General)
1960; 123: 37–44.
Ruijs, WL, et al.
How orthodox protestant parents decide on the vaccination of their children: a qualitative study. BMC Public Health
2012; 12: 408.
Ruijs, WL, et al.
How healthcare professionals respond to parents with religious objections to vaccination: a qualitative study. BMC Health Services Research
2012; 12: 231.
Van 't Klooster, TM, de Melker, HE. The national immunisation programme in the Netherlands: developments 2012. Bilthoven, The Netherlands: National Institute for Public Health and the Environment, 2012. Report 201001002/2012.
Van den Hof, S, et al.
Options for improvement of the Dutch measles vaccination schedule. Vaccine
2003; 21: 721–724.
Lee, MS, et al.
Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995–1997. Vaccine
2007; 19: 4644–4651.
Wetsteyn, JCFM, et al.
Measles outbreak at the intensive care [in Dutch]. Nederlands Tijdschrift voor Geneeskunde
2008; 152: 2032–2036.
Van den Hoek, A, et al.
Two cases of mild IgM-negative measles in previously vaccinated adults, the Netherlands, April and July 2011. Eurosurveillance
2011; 16: pii = 20028.
Poethko-Müller, C, Mankertz, A. Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titers in a German population-based cross-sectional study in children and adolescents (KiGGS). Vaccine
2011; 29: 7949–7959.
Christenson, B, Böttiger, M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine
1994; 12: 129–133.
Amela, C, Pachón, I, de Ory, F. Evaluation of measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey. European Journal of Epidemiology
2003; 18: 71–79.
Mossong, J, Putz, L, Schneider, F. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiology and Infection
2003; 132: 11–18.
Davidkin, I, et al.
Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. Journal of Infectious Diseases
2008; 197: 950–956.
Rota, MC, et al.
Measles serological survey in the Italian population: interpretation of results using a mixture model. Vaccine
2008; 26: 4403–4409.
Theeten, H, et al.
Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Epidemiology and Infection
2011; 139: 494–504.
Parker, RA, Erdman, DD, Anderson, LJ. Use of mixture models in determining laboratory criterion for identification of seropositive individuals: application to parvovirus B19 serology. Journal of Virological Methods
1990; 27: 135–144.
Vyse, AJ, et al.
Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiology and Infection
2006; 134: 1303–1312.